is not listed in the list of scheduled controlled substances in the USA. It is therefore not scheduled at the federal level in the United States, but it is possible that HU-210 could legally be considered an analog of Delta-9-THC (which is one of the substances controlled in Schedule I as "tetrahydrocannabinols"), and therefore sales or possession could potentially be prosecuted under the Federal Analogue Act. A brief profile of HU-210 written and published by the Drug Enforcement Administration (DEA) in 2009 (but subsequently removed from the DEA's website several years later) stated that HU-210 is a Schedule I controlled substance under the Controlled Substances Act due to being similar to THC. This indicates that the DEA might legally consider HU-210 to be an analogue of Delta-8-THC for the purposes of applying the Federal Analog Act to those that handle HU-210. An elucidation of the rationale for the DEA's claim was not presented, no references were cited, and the claim was eventually removed from the DEA's website. A version of the document (updated in 2013), now in PDF form, exists on the DEA Office of Diversion Control's website. Claimed in this possibly misleading though definitive sounding document, with the same lack of detailed explanation or citation, is: Alabama HU-210 is a Schedule I controlled substance in Alabama. Florida HU-210 is a Schedule I controlled substance, categorized as a hallucinogen, making it illegal to buy, sell, or possess in the state of Florida without a license. Vermont Effective January 1, 2016, HU-210 is a regulated drug in Vermont designated as a "Hallucinogenic Drug." Other HU Cannabinoids HU-211 HU-239 HU-243 HU-308 HU-320 HU-331 HU-336 HU-345 See also 11-Hydroxy-Delta-8-THC CP 47,497 JWH-018 References Further reading Primary alcohols Benzochromenes HU cannabinoids Designer drugs Phenols